ATI-501

N/A

Report date: 2024/06/18 20:00:07
NME

Base Information

Drug NameATI-501
Drug Alias NameATI-50001A-201ATI-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase JAK1
Therapy Area/IndicationsAlopecia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAclaris Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAlopecia

Other Information

ATC CodeN/A
Related LinksN/A